市场调查报告书
商品编码
1530698
2030 年替代蛋白质市场预测:按原产地、形式、生产流程、分销管道、应用和地区进行的全球分析Protein Alternatives Market Forecasts to 2030 - Global Analysis By Source, Form, Production Process, Distribution Channel, Application and By Geography |
根据 Stratistics MRC 的数据,2024 年全球替代蛋白市场规模为 275.5 亿美元,预计到 2030 年将达到 759.1 亿美元,预测期内复合年增长率为 18.4%。
替代蛋白质是替代或补充传统动物蛋白质的非传统蛋白质来源。这些替代蛋白质通常源自于植物、真菌或培养动物组织,为寻求永续、道德或健康相关饮食的个人提供了多种选择。大豆、扁豆和藜麦等植物蛋白因其完整的氨基酸谱和高营养价值而成为着名的例子。
根据联合国粮食及农业组织预测,到2050年,食品和饲料用谷物的需求量预计将从目前的近21亿吨增加到30亿吨左右。
素食者和素食主义者的数量不断增加
素食者和素食人口的成长正在推动对替代蛋白质和创新的需求,重塑食品产业格局。随着越来越多的人出于健康、环境和道德原因采用植物性饮食,对传统动物食品以外的蛋白质来源的需求正在增加。这种转变推动了大豆、豌豆、鹰嘴豆和大麻等植物性蛋白质的激增。替代蛋白的兴起不仅满足了纯素食者和素食者的偏好,也吸引了广大寻求更健康、更永续食品的人。
监管障碍
替代蛋白质市场面临重大挑战,监管障碍成为创新和市场进入的障碍。世界各地有关食品安全、标籤和成分核准的法规各不相同,这使得替代蛋白质产品的开发和分销变得复杂。在某些地区,对新原材料和製造方法的严格要求可能会延迟产品上市并增加製造商的成本。 「植物来源的」、「实验室种植的」和「培养的」等术语的不同定义和标准使监管合规性和消费者理解更加复杂。
对替代蛋白质的需求不断增长
对替代蛋白质不断增长的需求代表着全球食品产业的变革。这一趋势是由多种因素驱动的,包括环境问题、健康考量和道德动机。替代蛋白质包括多种来源,包括植物蛋白质(如大豆、豌豆和扁豆)、培养蛋白质(透过细胞农业生产)和新来源(如藻类和昆虫)。此外,越来越多的消费者选择这些替代蛋白,因为永续性、对环境影响低,且营养价值可与传统动物蛋白相媲美。
微生物风险和过敏反应
微生物风险来自于生产这些替代食品的製造过程,例如发酵和培养方法,如果不严格控制,可能会导致污染。消费者对食品安全和品质标准的期望加剧了这种担忧。过敏反应也是一个重大障碍,因为对常见植物性蛋白质(大豆、坚果等)和替代蛋白产品中使用的其他成分过敏的人可能会出现副作用。这些问题会影响消费者信心和监管,从而阻碍市场成长,导致产业参与者大力投资研发和采取严格的品管措施来减轻这些风险。
COVID-19 大流行对替代蛋白质市场产生了重大影响。随着危机的展开,供应链和製造中断对肉类等传统蛋白质来源的生产和分销带来了挑战。这导致消费者对替代蛋白质来源的兴趣和需求增加,例如植物性蛋白质,它们对供应链中断的抵抗力更强,并且具有健康和永续性。然而,这场大流行凸显了人们对通用感染疾病的担忧,并进一步增加了人们对植物蛋白和其他非传统蛋白质来源作为更安全替代品的兴趣。
藻类蛋白部分预计在预测期内成长最高
透过提供大豆和乳清等传统蛋白质来源的永续营养丰富的替代品,预计藻类蛋白质领域在预测期内将增长最大。藻类,特别是螺旋藻和小球藻等微藻类,营养丰富,富含必需胺基酸、维生素和矿物质。种植藻类是环保且扩充性的,因为与传统作物相比,它需要最少的土地和淡水。由于藻类蛋白不含大豆和乳製品中常见的过敏原,因此这项创新将吸引寻求植物性或素食饮食的消费者。
预计专卖店细分市场在预测期间的复合年增长率最高
透过提供针对注重健康的消费者的偏好定制的多样化和创新产品,预计专卖店领域在预测期内将实现最高的复合年增长率。这些商店专门满足对植物蛋白不断增长的需求,并提供豆腐、Tempeh、素肉和各种豆类产品等替代品。与传统超级市场不同,专卖店通常为纯素、素食者和弹性素食者提供精心挑选的高品质、小众产品。此外,它也是教育和探索的中心,引入新的蛋白质来源和永续食品选择,以促进环境责任。
由于人们对畜牧业相关健康和永续性议题的认识不断增强,以及越来越多的消费者采用素食和弹性饮食,欧洲地区在估计期间占据了最大的市场份额。植物性蛋白质提供了传统动物性蛋白质的可行替代品,并适应各种饮食偏好和生活方式。此外,食品科技创新正在开发模仿肉类和乳製品的味道、质地和营养成分的植物性产品,进一步推动该地区的成长。
预计欧洲地区在预测期内将显着成长。针对永续性、健康和动物福利的严格法规正在鼓励食品製造商在全部区域创新并实现产品多样化。促进植物性饮食、减少肉类消费和促进永续农业实践的政策将在该全部区域因此,欧洲已成为替代蛋白质的中心,吸引投资并推动市场成长,同时促进向更永续和健康的食品选择的转变。
According to Stratistics MRC, the Global Protein Alternatives Market is accounted for $27.55 billion in 2024 and is expected to reach $75.91 billion by 2030 growing at a CAGR of 18.4% during the forecast period. Protein alternatives refer to non-traditional sources of protein that can substitute or complement conventional animal-based proteins. These alternatives are typically derived from plants, fungi, or even cultivated animal tissues, offering diverse options for individuals seeking sustainable, ethical, or health-related dietary choices. Plant-based proteins, such as soybeans, lentils, and quinoa, are prominent examples due to their complete amino acid profiles and high nutritional value.
According to the Food and Agriculture Organization, by 2050, the demand for cereals is expected to increase from its current level of close to 2.1 billion tons to around 3 billion tons for both food and animal feed.
Increasing vegan and vegetarian population
The increasing vegan and vegetarian population is driving the demand and innovation in protein alternatives, reshaping the food industry landscape. As more people adopt plant-based diets for health, environmental, and ethical reasons, there's a growing need for protein sources beyond traditional animal products. This shift has spurred a surge in plant-based protein options such as soy, pea, chickpea, and hemp, which are not only rich in protein but also offer diverse nutritional benefits. The rise in protein alternatives is not only meeting the dietary preferences of vegans and vegetarians but also appealing to a broader audience seeking healthier and sustainable food options.
Regulatory hurdles
The Protein Alternatives Market faces significant challenges due to regulatory hurdles, which pose barriers to innovation and market entry. Regulations governing food safety, labeling, and ingredient approval vary globally, complicating the development and distribution of alternative protein products. In some regions, stringent requirements for new ingredients or production methods can delay product launches and increase costs for manufacturers. Differing definitions and standards for terms like "plant-based," "lab-grown," or "cultivated" further complicate regulatory compliance and consumer understanding.
Rising demand for alternate protein
The rising demand for alternative proteins signifies a transformative shift in the global food industry. This trend is driven by several factors, including environmental concerns, health considerations, and ethical motivations. Alternative proteins encompass a diverse range of sources such as plant-based proteins (like soy, pea, and lentils), cultured proteins (produced through cellular agriculture), and novel sources (such as algae or insects). Furthermore, consumers are increasingly opting for these alternatives due to their perceived sustainability, lower environmental impact, and nutritional benefits comparable to traditional animal-based proteins.
Microbial risk and allergic reactions
Microbial risks arise from the production processes involved in creating these alternatives, such as fermentation or cultivation methods, which may lead to contamination if not rigorously controlled. This concern is amplified by consumer expectations for food safety and quality standards. Allergic reactions pose another significant hurdle, as individuals with allergies to common plant-based proteins (e.g., soy, nuts) or other ingredients used in alternative protein products may experience adverse effects. These issues hinder market growth by affecting consumer confidence and regulatory scrutiny, prompting industry players to invest heavily in research, development, and stringent quality control measures to mitigate these risks.
The COVID-19 pandemic significantly influenced the protein alternatives market. As the crisis unfolded, disruptions in supply chains and manufacturing posed challenges to the production and distribution of traditional protein sources such as meat. This led to increased consumer interest and demand for alternative protein options like plant-based proteins, which were perceived as more resilient to supply chain disruptions and were also associated with health and sustainability benefits. However, the pandemic highlighted concerns over zoonotic diseases, further driving interest in plant-based and other non-traditional protein sources as safer alternatives.
The Algae Protein segment is expected to be the largest during the forecast period
Algae Protein segment is expected to be the largest during the forecast period by offering a sustainable and nutritious alternative to traditional protein sources like soy and whey. Algae, particularly microalgae such as spirulina and chlorella, are rich in essential amino acids, vitamins, and minerals, making them highly nutritious. Algae cultivation requires minimal land and freshwater compared to traditional crops, making it environmentally friendly and scalable. This innovation appeals to consumers seeking plant-based or vegan diets, as algae proteins are free from allergens commonly found in soy and dairy products.
The Specialty Store segment is expected to have the highest CAGR during the forecast period
Specialty Store segment is expected to have the highest CAGR during the forecast period by offering a diverse range of innovative products tailored to the preferences of health-conscious consumers. These stores cater specifically to the growing demand for plant-based proteins, offering alternatives such as tofu, tempeh, seitan, and various legume-based products. Unlike conventional supermarkets, Specialty Stores often provide a curated selection of high-quality, niche products that appeal to vegan, vegetarian, and flexitarian diets. Furthermore, they serve as hubs for education and exploration, showcasing new protein sources and sustainable food options that promote environmental responsibility.
Europe region dominated the largest share of the market during the extrapolated period, due to rising awareness of health and sustainability concerns associated with animal farming, coupled with a growing number of consumers adopting vegetarian or flexitarian diets. Plant-based proteins offer a viable alternative to traditional animal-derived proteins, catering to diverse dietary preferences and lifestyles. Furthermore, innovations in food technology have led to the development of plant-based products that mimic the taste, texture, and nutritional profile of meat and dairy products, further accelerating regional growth.
Europe region is estimated to witness substantial growth over the projection period. Stringent regulations aimed at sustainability, health and animal welfare are compelling food manufacturers to innovate and diversify their product offerings across the region. Policies promoting plant-based diets, reducing meat consumption, and fostering sustainable agricultural practices are creating a conducive environment for the expansion of protein alternatives such as plant-based proteins, algae-based proteins and cultured meat throughout the region. As a result, Europe is emerging as a hub for protein alternatives, attracting investments and driving market growth while promoting a shift towards more sustainable and healthy food choices.
Key players in the market
Some of the key players in Protein Alternatives market include Archer Daniels Midland Company, Aspire Food Group, Axiom Foods Inc, Bluebiotech International GmbH, Burcon Nutrascience Corporation, Calysta, Inc, Cargill, Incorporated, Cellena Inc, Glanbia PLC, JR Unique Foods Ltd, Kerry Group Plc and Plantible Foods, Inc.
In February 2024, Roquette expanded its Nutralys plant protein line by launching four new pea protein products, encompassing isolates, hydrolysates, and textured variants. These versatile pea proteins are designed to address formulation challenges in plant-based foods and high-protein nutritional products. They pave the way for innovation in various items, including nutritional bars, protein beverages, and plant-based meat and dairy alternatives.
In May 2023, ADM and Air Protein established a Strategic Development Agreement (SDA) to jointly develop innovative protein sources for nutrition. Air Protein produces protein through air-based techniques that bypass traditional agriculture and farmland, mitigating supply chain risks. This collaboration combines ADM's expertise in nutrition, formulation, and research with Air Protein's pioneering landless agriculture platform to enhance cost-effective protein ingredients for North American meat substitutes.
In June 2022, AMCO Proteins (US) acquired a 40,000-square-foot facility in Mountain Top, Pennsylvania, which includes five food-grade production rooms and storage space for over 500 pallets. This new facility is anticipated to boost and expand the company's spray drying, blending, and milling operations, thereby enhancing its business capabilities in these areas.
In April 2022, ADM made a strategic investment of USD 300 million to enhance alternative protein production at its Decatur, Illinois plant, aiming to double the facility's soy extrusion capacity. This investment also includes the construction of a Protein Innovation Center, equipped with labs, test kitchens, and pilot-scale production facilities, to strengthen the company's R&D capabilities.